Skip to main content
Article thumbnail
Location of Repository

The Role of Copy Number Variation in Susceptibility to Amyotrophic Lateral Sclerosis: Genome-Wide Association Study and Comparison with Published Loci

By Louise V. Wain, Inti Pedroso, John E. Landers, Gerome Breen, Christopher E. Shaw, P. Nigel Leigh, Robert H. Brown, Martin D. Tobin and Ammar Al-Chalabi

Abstract

Background :\ud The genetic contribution to sporadic amyotrophic lateral sclerosis (ALS) has not been fully elucidated. There are increasing efforts to characterise the role of copy number variants (CNVs) in human diseases; two previous studies concluded that CNVs may influence risk of sporadic ALS, with multiple rare CNVs more important than common CNVs. A little-explored issue surrounding genome-wide CNV association studies is that of post-calling filtering and merging of raw CNV calls. We undertook simulations to define filter thresholds and considered optimal ways of merging overlapping CNV calls for association testing, taking into consideration possibly overlapping or nested, but distinct, CNVs and boundary estimation uncertainty.\ud \ud Methodology and Principal Findings :\ud In this study we screened Illumina 300K SNP genotyping data from 730 ALS cases and 789 controls for copy number variation. Following quality control filters using thresholds defined by simulation, a total of 11321 CNV calls were made across 575 cases and 621 controls. Using region-based and gene-based association analyses, we identified several loci showing nominally significant association. However, the choice of criteria for combining calls for association testing has an impact on the ranking of the results by their significance. Several loci which were previously reported as being associated with ALS were identified here. However, of another 15 genes previously reported as exhibiting ALS-specific copy number variation, only four exhibited copy number variation in this study. Potentially interesting novel loci, including EEF1D, a translation elongation factor involved in the delivery of aminoacyl tRNAs to the ribosome (a process which has previously been implicated in genetic studies of spinal muscular atrophy) were identified but must be treated with caution due to concerns surrounding genomic location and platform suitability.\ud \ud Conclusions and Significance :\ud Interpretation of CNV association findings must take into account the effects of filtering and combining CNV calls when based on early genome-wide genotyping platforms and modest study sizes

Publisher: Public Library of Science (PLoS)
Year: 2009
DOI identifier: 10.1371/journal.pone.0008175
OAI identifier: oai:lra.le.ac.uk:2381/7387
Journal:

Suggested articles

Citations

  1. (2007). A human phenome-interactome network of protein complexes implicated in genetic disorders. doi
  2. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. doi
  3. (2002). Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. doi
  4. (2009). Al-Chalabi A doi
  5. Ammar Al-Chalabi2.* 1Departments of Health Sciences and Genetics, University of Leicester, Leicester, United Kingdom, 2MRC Centre for Neurodegeneration Research,
  6. (2006). Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. doi
  7. (2008). Analysis of genome-wide copy number variation in Irish and Dutch ALS populations. doi
  8. (2006). ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. doi
  9. (2007). Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. doi
  10. (2009). Avoiding the high Bonferroni penalty in genome-wide association studies. doi
  11. (2007). Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. doi
  12. (2007). Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. doi
  13. (2008). Copy-number variation in sporadic amyotrophic lateral sclerosis: a genome-wide screen. doi
  14. (2008). Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease. doi
  15. (1999). Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. doi
  16. (2004). Detection of large-scale variation in the human genome. doi
  17. (2006). Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. doi
  18. (2004). DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). doi
  19. (2006). Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. doi
  20. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. doi
  21. (2008). Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. doi
  22. (2009). Genomic copy number variation, human health, and disease. doi
  23. (2008). Genotype, haplotype and copy-number variation in worldwide human populations. doi
  24. (2008). High-resolution mapping of expression-QTLs yields insight into human gene regulation. doi
  25. (2006). Highresolution genomic profiling of chromosomal aberrations using Infinium wholegenome genotyping.
  26. (1997). Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome. doi
  27. (2008). Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. doi
  28. (2009). Identifying Relationships Among Genomic Disease Regions: Predicting Genes at doi
  29. (2008). Integrated detection and population-genetic analysis of SNPs and copy number variation. doi
  30. (2007). ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. doi
  31. (1991). Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. doi
  32. (1994). Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. doi
  33. (1999). Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. doi
  34. (2003). Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis. doi
  35. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. doi
  36. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. doi
  37. (1998). Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. doi
  38. (1998). Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). doi
  39. (2008). Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. doi
  40. (2007). Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? doi
  41. (2007). Pathway-based approaches for analysis of genome-wide association studies. doi
  42. (2007). PennCNV: An integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. doi
  43. (2007). QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. doi
  44. (2009). Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. doi
  45. (2006). Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. doi
  46. (2003). Spastin and paraplegin gene analysis in selected cases of motor neurone disease (MND). doi
  47. (2008). Strong association of de novo copy number mutations with sporadic schizophrenia. doi
  48. (2009). susceptibility loci for sporadic amyotrophic lateral sclerosis. doi
  49. (2008). TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. doi
  50. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. doi
  51. (2006). The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. doi
  52. (2001). The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.
  53. (2009). Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration. doi
  54. (1994). Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.